KYMERA THERAPEUTICS I
43.04
08-十月-24 14:59:58
15 分钟延时
股票
+0.83
+1.97%
今日范围
42.41 - 43.90
ISIN
N/A
来源
NASDAQ
-
29 7月 2021 06:00:02 条件 Nasdaq GlobeNewswire
-
06 7月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
30 6月 2021 20:45:35 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces Proposed Public Offering of Common Stock
28 6月 2021 15:36:38 条件 Nasdaq GlobeNewswire
-
28 6月 2021 05:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Appoints Elaine Caughey, MBA, as Chief Business Officer
21 6月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
02 6月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
26 5月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
10 5月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
06 5月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Appoints Juliet Williams, PhD, as Senior Vice President, Head of Biology
05 5月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics to Present at Upcoming May Investor Conferences
04 5月 2021 06:00:02 条件 Nasdaq GlobeNewswire
-
03 5月 2021 15:00:40 条件 Nasdaq GlobeNewswire
-
Kymera Therapeutics Honored by Boston Business Journal as a 2021 Best Places to Work Company
19 4月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
10 4月 2021 07:30:00 条件 Nasdaq GlobeNewswire